FP receptor — Drug Target

All drugs that target FP receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

prostaglandin analogue · Prostaglandin analogue · Prostaglandin analog

Phase 3 pipeline (1)

• Xalatan®/DE-130A · Santen SAS · prostaglandin analogue · Ophthalmology
  Xalatan is a prostaglandin analogue that reduces intraocular pressure by increasing uveoscleral outflow.

Phase 2 pipeline (3)

• Bimatoprost Solution 2 · Allergan · Prostaglandin analogue · Ophthalmology
  Prostaglandin F2α analogue
• Bimatoprost cutaneous solution 0.03% · Allergan · Prostaglandin analog · Ophthalmology
  Bimatoprost activates the prostaglandin F2 alpha receptor (FP receptor), leading to increased uveoscleral outflow of aqueous humor and reduced intraocular pressure.
• Bimatoprost Sustained Release Implant · AbbVie · Prostaglandin analog · Ophthalmology
  Bimatoprost Sustained Release Implant works by releasing bimatoprost, a prostaglandin analog, to lower intraocular pressure.